STT COMP IBX FA LONGSP 3.5cMarket Cap $40mIBX is a biotech I’ve...

  1. 448 Posts.
    lightbulb Created with Sketch. 7
    STT COMP IBX FA LONG

    SP 3.5c
    Market Cap $40m

    IBX is a biotech I’ve been following for several years. It’s running a trial for the detection of breast cancer cells using nanoparticles.

    The trial and comms have been slow and IBX mtg doesn’t waste time on fluffy comms, so holders tend to sell when there’s no news.

    It seems to have hit a low, and with quarterly news due at the end of the month should rise at least 10% based on past cycles and potentially up to 25% or more with any good news. The last significant news saw it rise to 20c.

    Plenty of money in the bank so it’s not going broke any time soon.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.